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Either  during  gestation  or lactation,  the experimental  mouse  dams  received  one  of  the
following  treatments:  (a) diet  free  of  pesticide;  (b) diet  enriched  with  atrazine  (ATZ);
31.0  g kg−1;  (c)  diet  free  of pesticide  + oral  vitamin  E (-tocopherol;  200  mg  kg−1 per
mouse);  and  (d) diet  enriched  with  ATZ  (31.0  g  kg−1)  +  oral  vitamin  E (200 mg  kg−1 per
mouse).  At the  weaning,  pups  and  dams  were killed  and  selected  organs  and  blood  samples
were  collected  for analyses.  Compared  with the control  results,  ATZ  induced  alteration  in
a number  of  biochemical  and  histopathological  parameters  either  in  the dams  or their  off-
spring. The  ameliorative  effect  of  vitamin  E, based  on  estimating  the  “Ameliorative  Index;
AI” to malondialdehyde  (MDA)  and  superoxide  dismutase  (SOD)  ranged  between  0.95  and
1.06 (≈1.0)  for  the  dams  and  the pups  either  in  gestational  or lactational  exposure  routes.
In general,  the  mouse  pups  were  more  vulnerable  to ATZ  toxicity  than their  mothers  andactation exposure  during  gestation  was  suggested  to be more  effective  than  during  lactation.  The
ﬁndings  may  support  the  need  to further  investigating  the  adverse  effects  of  exposure  to
low doses  of  commonly  used  pesticides,  especially  during  pregnancy  and breast-feeding  as
well as  effects  on newborn  child.
© 2014  Published  by  Elsevier  Ireland  Ltd.  This  is  an open  access  article  under  the  CC
BY-NC-ND license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).. Introduction
Atrazine, ATZ (6-chloro-N-ethyl-N-isopropyl-1,3,5-
riazinediyl-2,4-diamine; IUPAC) is a chloro-S-triazine
ompound used as a selective pre-emergence and post-
mergence herbicide for the control of weeds in a variety
f  agricultural crops, as well as in forestry and for non-
elective weed control on non-crop areas [1]. In 1991, the
S-EPA  established a Maximum Contaminant Level (MCL)
∗ Corresponding author. Tel.: +20 2 33371211; fax: +20 2 33370931.
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214-7500/© 2014 Published by Elsevier Ireland Ltd. This is 
http://creativecommons.org/licenses/by-nc-nd/3.0/).of 3.0 g/l for ATZ in drinking water. The most signiﬁcant
regulatory decision in recent years occurred in 2003,
after the EU, US, and other nations decided to re-examine
the safety of ATZ in light of new evidence. At that time,
research had expanded beyond toxicity studies and was
beginning to investigate long-term, low-dose exposures in
animals,  particularly female and fetal animals [2].
Some European countries have included ATZ in the
list  of pesticide residues to be controlled because it is a
potential contaminant due to its chemical characteristics,
including lipophilicity, slow hydrolysis, and moderate to
low  water solubility, and high solubility in organic solvents
with  high absorption by organic matter, clay and fat tissues
an open access article under the CC BY-NC-ND license
icology R54 S.A. Mansour et al. / Tox
[3]. Due to inability to keep water contamination below
0.1  ppb, which is a uniform limit for the residue of any pes-
ticide  in drinking and groundwater in the European Union
(EU),  the EU regulators announced the ban of ATZ use. How-
ever,  in the rest of the world the use of ATZ continues with
few,  if any, restrictions, and it is even the most frequently
detected pesticide in ground- and surface water of the USA
[4].
Possible  exposure to ATZ can be assumed due to the
application to agricultural land and contamination of sur-
face  and ground water [5]. ATZ is readily absorbed through
gastrointestinal tract [6]. Occupational exposure may  occur
through  both inhalation and dermal absorption during
its  manufacture, its formulation and its application by
spraying. It is found widely, together with its dealkylated
degradation products, in rivers, lakes, estuaries, ground-
water and reservoirs. In drinking water, the levels rarely
exceed 1 g/l. Surveys of various foods and feeds have gen-
erally  indicated no detectable ATZ residue. Although ATZ
generally  has low level of bioaccumulation in ﬁsh, it does
accumulate in brain, gall bladder, liver and gut of some
ﬁshes [7]. Therefore, consumption of contaminated ﬁsh can
also  contribute to human exposure. The residues of ATZ
were  found in the farmers’ blood and urine [8].
The major site for ATZ detoxiﬁcation is liver, where it
is  undergoing biotransformation throughout phase I and
phase  II reactions. In rodent species, two cytochrome P450
(CYP)  enzymes (CYP1A & CYP2B) are distinctively involved
in  ATZ biotransformation [9]. ATZ has a lot of adverse effect
on  health such as tumors, breast, ovarian, and uterine can-
cers  as well as leukemia and lymphoma. It is an endocrine
disrupting chemical interrupting regular hormone func-
tion  and alters reproductive function not only in human
[10],  but also in many other species such as developing
alligators [11], birds [12], goat [13], and as most vulnera-
ble  amphibians [14,15] and ﬁsh [16], causing birth defects,
reproductive tumors, and weight loss in amphibians as well
as  humans. It also causes induction of the detoxifying hep-
atic  microsomal oxidative enzymes, continual synthesis of
esterases,  physiological adaptation to decreased esterase
levels, and adaptation of cholinergic receptors [17]. Thus,
interfering with the biochemical pathways mechanisms
including reproductive functions as a whole and also gene
expression changes, ATZ inevitably affects biodiversity and
causes  environmental havoc [18].
With regard to fetal and childhood exposures, the US
Department of Health and Human Services arrived at a con-
clusion  that it is not known whether ATZ or its metabolites
can be transferred from a pregnant mother to a develop-
ing fetus through the placenta or from a nursing mother
to  her offspring through breast milk [19]. In their article,
Pathak and Dikshit [17] reported the same ATSDR’s aware-
ness.  However, Stoker et al. [20] found that 3 h following
administration of 14C-ATZ to the Wistar rat, there was a
distribution of 14C-chlorotriazines (14C-ClTRI) [refer to all
residues  of the initial dose of 14C atrazine], to the organs
of  the dam, with the highest amounts in the liver and kid-
ney  (1.1 and 0.3% of the administered dose, respectively).
Recently, Fraites et al. [21] quantiﬁed the distribution of
ATZ  and its chlorinated metabolites in maternal, fetal, and
neonatal  ﬂuid and tissue samples following gestationaleports 1 (2014) 53–68
and/or lactational exposure of Sprague Dawley dams to
ATZ  at different doses. Dose-dependent levels of chloro-
triazines, primarily diaminochlorotriazine (DACT), were
present  in most samples analyzed, including fetal tis-
sue.
There  is growing evidence that exposure to xenobiotics
(either pharmaceuticals or environmental chemicals) dur-
ing  gestation may  result in a variety of adverse outcomes
when the developing organism reaches adulthood. Oral
exposure to ATZ is known to alter endocrine and repro-
ductive function in adult and peripubertal rodents of both
sexes  [22–25], but few studies have investigated the effects
of  ATZ exposure in utero or during the perinatal period.
A  number of studies have shown that ATZ can promote
oxidative stress, by increasing the concentration of reactive
oxygen species (ROS) and products of oxidative damage
such as lipid peroxides, and therefore inﬂuencing the activ-
ity  of antioxidant enzymes (AOE) [6,26–28]. Liver is the ﬁrst
target  of ingested oxidants and also very important tissue in
defense  against oxidative stress. Testes also possess proper
antioxidant defense, and changes in the activity of antiox-
idant  enzymes have been recorded in xenobiotic-exposed
animals [29].
Numerous foods provide vitamin E. Nuts, seeds, and
vegetable oils are among the best sources of alpha-
tocopherol, and signiﬁcant amounts are available in green
leafy  vegetables and fortiﬁed cereals [30]. Vitamin E is
the  collective name for a group of fat-soluble compounds
with distinctive antioxidant activities [31]. Naturally occur-
ring  vitamin E exists in eight chemical forms (alpha-,
beta-, gamma-, and delta-tocopherol and alpha-, beta-,
gamma-, and delta-tocotrienol) that have varying levels
of  biological activity [31]. Alpha- (or -) tocopherol is
the  only form that is recognized to meet human require-
ments. The research has not found any adverse effects
from consuming vitamin E in food. However, high doses
of  -tocopherol supplements can cause hemorrhage and
interrupt blood coagulation in animals, and in vitro data
suggest that high doses inhibit platelet aggregation [32].
Vitamin  E is a fat-soluble antioxidant that stops the pro-
duction of reactive oxygen species (ROS) formed when fat
undergoes oxidation. Scientists are investigating whether,
by  limiting free-radical production and possibly through
other mechanisms, vitamin E might help prevent or delay
the  chronic diseases associated with free radicals. In addi-
tion  to its activities as an antioxidant, vitamin E is involved
in  immune function and, as shown primarily by in vitro
studies of cells, cell signaling, regulation of gene expression,
and  other metabolic processes [31]. Vitamin E is an impor-
tant  biological free radical scavenger in the cell membranes
[33]. Administration of vitamin E at 100 mg  kg−1 bw to Wis-
tar  rats treated with ATZ (300 mg  kg−1 bw) ameliorated the
effects  of ATZ suggesting it as potential antioxidant against
ATZ  -induced oxidative stress [6].
Most studies on ATZ toxicity to rodents during ges-
tation/lactation were carried out on doses much higher
than  the dose characterized as the “acceptable daily intake,
ADI”  (0.005 mg  kg−1 food per day). Examples for the doses
used  in this respect were 1, 5, 20 and 100 mg kg−1/day
[20,21,34,35]; 100 mg  kg−1/day [36]; 50–100 mg  kg−1/day
[37];  and 50–200 mg  kg−1/day [18].
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Women, during pregnancy and lactation, may  expose to
ow  doses of ATZ from different environmental sources. In
he  same protocol of the present study we recently inves-
igated the effect of exposure of mouse dams to ATZ during
he  overall period of gestation and lactation, and the reﬂec-
ion  of such exposure on the offspring. It was found of
nterest, in the present study, to elucidate and compare ATZ
oxicity  to each exposure stage, and to assess the amelio-
ative effect of vitamin E supplementation. In the course
f  the present study, we will base our investigation on the
DI  of ATZ, which may  be the lowest dose to be tested on
regnant and lactating mouse dams.
. Materials and methods
.1.  Reagents
High purity PESTANAL® Analytical Standard of Atrazine
97.4%) was purchased from Fluka (Riedel-de Haën, France)
nd  added as a component of rodent nuggets at a dose
f  25 g/kg of food. This dose allowed the mice to ingest
he  equivalent of 0.005 mg  kg−1 food per day (ADI) deﬁned
or  humans by Food & Agricultural Organization/World
ealth Organization [38] that was extrapolated for mice
n  the basis of mean body weight. Information on the
oxicity of ATZ was obtained from ExToxNet (ExToxNet:
ttp://extoxnet.orst.edu/).
d-l -tocopherol acetate was purchased from Fluka
Riedel-de Haën, France). The vitamin was dissolved in corn
il  (120 mg/3 mL). Each mouse (with a mean body weight
f  nearly equal to 20 g) received 100 l by oral gavages
wice a week on the ﬁrst and fourth day. This dose equals
00  mg  kg/mouse twice a week based on the dosage fol-
owed  by Kalender et al. [39].
.2. Preparation of pesticide enriched feed
ATZ (0.125 mg)  was dissolved in 1 ml  methanol. The
esulting solution was mixed with acetone (1/9; v/v) and
ispersed on 10 g of the vitamin mixture powder (vitaminic
ixture 200, Scientiﬁc Animal Food Engineering, Safe,
rance). The vitamin powder containing 125 g ATZ was
hen  homogenized in a rotavapor (Laborota 4000 Fischer
ioblock, France) for 30 min  at 45 ◦C to evaporate the sol-
ent  and then mixed for 50 min  at room temperature with
he  remaining quantity of vitamin mixture (40 g) needed
o  make the rodent nuggets (5 kg). The vitamin powder
nriched with ATZ was then sent to the National Institute of
gricultural Research (INRA) animal feed preparation unit
UPAEINRA, Paris, France) where vitamins (1%) and mineral
omponents (7%) were mixed with the other components
f the rodent nuggets. The presence of the ATZ was quan-
iﬁed  by Euroﬁns (Nantes, France). The ﬁnal quantity was
round  that we expected (i.e., 0.031 mg  kg−1; LC/MS/MS).
he control feed was prepared as described above with a
ixture  of methanol/acetone (1/9, v/v) but lacking pesti-
ide.  It was analyzed for the presence of the endogenous
esticide (ATZ) and also for the presence of the most
ommon pesticides found in the environment (including
he organophosphorus, OC and pyrethroid pesticides, and
olychlorobiphenyls). The results showed that nuggets ineports 1 (2014) 53–68 55
control  food do not contain pesticides at the detectable
level (0.01 mg  kg−1).
2.3. Animals
Ten-week-old female and male C57 BL/6J mice were
purchased from Charles River Laboratories (Domaine des
Oncins-BP  109, 69592 L’arbresle, Cedex, France). Mean
body  weights were 20 ± 2 g for females and males. The ani-
mals  were acclimatized for 2 weeks before starting dosing.
Thirty-two (32) virgin female mice were distributed into
16  cages. In each cage, one male was  placed overnight and
the  presence of spermatozoa was  checked in the vaginal
smear in the following morning. This day was connoted as
gestation  day 0 (GD 0). At that time, pregnant females were
divided  into 2 major groups, each of 16 animals, individu-
ally  housed in clean plastic cages in the laboratory animal
room  (23 ± 2 ◦C; 40% RH), fed on the prepared diet and tap
water  was  allowed ad libitum. One of the two  major groups
was  speciﬁed as a “Gestation Group (G)”, while the other a
“Lactation  Group (L). The G group received the tested treat-
ments  during gestation only (20 days), while the L group
was  treated during lactation only (20 days). The day of par-
turition  was considered day 0 of lactation, postnatal day 0
(PND  0). The offspring of each litter were counted, sexed
and  each litter was randomly reduced to 6 pups of equal
number of sexes to maximize the lactation performance
[40]. The experimental work on animals was performed in
Toxalim  Unit, INRA, Toulouse (France), and in accordance to
its  institutional ethical committees in an accredited animal
house.
2.4.  Experimental design
During  gestation period, the experimental mouse dams
(D)  received one of the following treatments: (a) diet free
of  pesticide; control (CD); (b) diet enriched with ATZ;
31.0  g kg−1 (AD); (c) diet free of pesticide + oral vita-
min  E (-tocopherol); 200 mg/kg−1 per mouse (VD); and
(d)  diet enriched with ATZ; 31.0 g kg−1 + oral vitamin E;
200  mg  kg−1 per mouse (AVD). The dose of vitamin E was
divided into 2 equal portions and given twice a week. Pups
of  the experimental dams were designated as CP, AP, VP
and  AVP, to sign control, ATZ, vit E and ATZ + vit E treated
groups, respectively.
Similarly, the group of lactation (L) constituted of four
subgroups of mouse dams with their pups and received the
same  treatments, mentioned above, during lactation period
only.
At  the end of weaning, blood samples were taken from
the  facial artery of each animal (dams and pups) and added
to  heparinized centrifuge tubes (Multivette®, SARSTED,
Germany) for separating plasma. Centrifugation was per-
formed  on Sigma 1K15 Bioblock Scientiﬁc (Subra, France)
for  10 min  at 4 ◦C and 4000 rpm (1400 × g). The plasma
were kept in eppendorf tubes and stored at (−80 ◦C). Then
the  animals were sacriﬁced by cervical dislocation, and the
heart,  spleen, liver, kidneys, testes or ovaries were removed
and  weighted. Small pieces of organs were kept in 10% for-
malin  for histopathological studies. Other pieces of liver
were  packed in aluminium sheets and kept in nitrogen
icology R56 S.A. Mansour et al. / Tox
(−80 ◦C) for certain biochemical estimations. The fraction-
ated blood samples and specimens of internal organs were
shipped  frozen, in addition to formaldehyde – reserved
specimens, to the National Research Centre (NRC), Cairo,
Egypt  for biochemical analyses and histopathological stud-
ies.
2.5.  Biochemical analyses
These  included butyryl cholinesterase (BuChE), alka-
line  phosphatase (ALP), urea, Malondialdehyde (MDA) and
super  oxide dismutase (SOD). Measurements were per-
formed  spectrophotometrically using a Shimadzu UV-VIS
Recording 2401 PC (Japan), and in accordance with the
manufacturer’s instructions given in the pamphlets. The
activity  of plasma cholinesterase (BuChE; EC 3.1.1.8) was
measured at 405 nm and expressed in units per liter using
the  method of Knedel and Böttger [41]. ALP (EC 3.1.1) was
measured in plasma at 510 nm in terms of international
units per liter according to Belﬁeld and Goldberg [42].
Concentration of urea (milligram per deciliter) was deter-
mined  in plasma at 550 nm using the method of Fawcett
and Scott [43]. MDA  and SOD activities were determined
in liver tissues, based on methods published by Satoh [44]
and  Nishikimi et al. [45], respectively. Spectrophotometric
measurements were carried out at 534 nm for lipid perox-
ide,  in terms of MDA, and expressed in nanomole per gram
tissue.  SOD measurements at 560 nm were calculated in
terms  of units per gram liver tissue.
2.6. Histology studies
Liver,  kidneys, ovaries and testes from the experimen-
tal mice were dissected and ﬁxed in 10% neutral formalin,
dehydrated in ascending grades of alcohol and imbed-
ded in parafﬁn wax. Parafﬁn sections (5 mm thick) were
stained for routine histological study using haematoxylin
and eosin (H&E). Two slides were prepared for each mouse;
each  slide contained two sections for each organ. Ten ﬁeld
areas  for each section were selected and examined for
histopathological changes under light microscope (400×
magniﬁcations). The histopathology was carried out in
the  Pathology Department, Faculty of Veterinary Medicine,
Cairo  University, Cairo, Egypt. Tissue injury in the examined
organs was scored in different ratings according to Önder
et  al. [46].
2.7.  Statistical analysis
The  data were analyzed by using GraphPad
Prism 5 Demo (www.graphpad.com/downloads/docs/
Prism5Regression.pdf),  and expressed as means ± S.E.
Paired samples (t) test was used to compare the data of
the  control with those of treatments, where P < 0.05 and
P  < 0.01 were considered for signiﬁcant and high signiﬁcant
differences, respectively. When P > 0.05, values were not
signiﬁcantly different from one another.eports 1 (2014) 53–68
3. Results
3.1. Signs of toxicity and observations
All animals were carefully observed during gestation
and lactation periods. Generally, the experimental animals
showed normal behavior except signs of restless on the
dams  during gestation period. The number of pups per each
female  ranged between 6 and 8 of nearly 1:1 sex ratio.
3.2.  Body and relative organs weights
The initial starting body weight of mouse dams was
approximately 20 g/animal. In the G experimental group,
the  mean body weight of control mothers (CD), at the end of
experimental period, recorded 29.70 g which did not differ
signiﬁcantly than body weights of the other tested treat-
ments. The body weight of male pups in ATZ treatment (AP;
11.84  g) and female pups in vitamin treatment (VP; 11.48 g)
was  signiﬁcantly (P < 0.05) lower than that of the corre-
sponding control values (Table 1). Generally, the internal
organs weights relative to body weights showed no sig-
niﬁcant  differences between the tested treatments, except
for  liver and heart of ATZ-treated dams which showed val-
ues  signiﬁcantly differed than those of the corresponding
control values. Also, signiﬁcant difference was  recorded for
the  relative weight of kidneys from ATZ-female pups (1.47%
compared to 1.296% for the control treatment; Table 1).
In  the lactation experiment, L (Table 2), the mean body
weight of control mothers (CD) or male and female pups
(CP)  did not differ signiﬁcantly among the other tested
treatments. The relative weight of liver from ATZ (AP;
6.342%) or ATZ + vitamin (AVP; 6.982%) – female pups
showed signiﬁcant (P < 0.05) and high signiﬁcant (P < 0.01)
elevations compared to control value (5.256%). The rela-
tive  weight of heart from male and female pups exposed
to  ATZ + vitamin treatment showed signiﬁcant decreases,
while ovaries from female pups exposed to ATZ treatment
(AP; 0.748%) showed high signiﬁcant elevation compared
to  the corresponding control value (CP; 0.080%).
The relative weights of liver, heart, spleen and
ovary/testes in the G experimental group, as well as kid-
neys,  spleen and testes in the L experimental group did
not  show signiﬁcant differences among the pups of these
treatments (Tables 1 and 2).
3.3. Biochemical analyses
Due  to the little amount of blood obtainable from
the tested mouse, the estimated biomarkers were carried
out  on alkaline phosphatase (ALP), butyryl cholinesterase
(BuChE) and urea in plasma, as well as malondialdehyde
(MDA) and superoxide dismutase (SOD) in liver tissues. The
results  of these parameters are represented by column his-
tograms  designated by asterisks for the values of signiﬁcant
differences than the control values.
Control values of ALP recorded 75.3, 56.0 and 56.3 IU/l
for  the mouse dams (CD), male pups CP (M)  and female
pups CP (F), respectively, in gestational exposure experi-
ment  (Fig. 1a). The values recorded for ATZ-treated dams,
as  well as male and female pups were higher than the
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Table 1
Body  and relative organs weights of mouse dams and their pups exposed to atrazine, with and without vitamin E, during gestation.
Treatment groups B. Wt.  (g) Relative organs weights (%)
Liver Kidneys Heart Spleen Ovary/testes
CD 29.70 ± 0.87 5.353 ± 0.33 1.387 ± 0.09 0.8733 ± 0.003 0.3900 ± 0.03 0.1200 ± 0.01
AD  30.43 ± 0.77 6.733 ± 0.33* 1.180 ± 0.07 0.7700 ± 0.03* 0.3300 ± 0.02 0.1133 ± 0.03
VD  28.00 ± 0.61 5.613 ± 0.59 1.330 ± 0.07 0.6833 ± 0.07 0.3433 ± 0.01 0.07667 ± 0.02
AVD  27.70 ± 0.47 5.953 ± 0.60 1.370 ± 0.08 0.7467 ± 0.13 0.4000 ± 0.03 0.1133 ± 0.01
Pups  M F M F M F M F M F M F
CP 14.10 ± 0.62 12.78 ± 0.38 5.312 ± 0.51 5.298 ± 0.13 1.248 ± 0.05 1.296 ± 0.04 0.6240 ± 0.04 0.6960 ± 0.04 0.4820 ± 0.03 0.5060 ± 0.03 0.5600 ± 0.04 0.1300 ± 0.01
AP  11.84 ± 0.60* 12.68 ± 0.50 5.108 ± 0.71 5.150 ± 0.45 1.346 ± 0.03 1.470 ± 0.07* 0.6340 ± 0.03 0.6140 ± 0.04 0.5900 ± 0.05 0.5960 ± 0.07 0.5780 ± 0.02 0.1100 ± 0.01
VP  14.16 ± 0.71 11.48 ± 0.32* 4.992 ± 0.23 4.870 ± 0.19 1.192 ± 0.03 1.356 ± 0.03 0.5940 ± 0.02 0.7100 ± 0.09 0.4840 ± 0.04 0.5660 ± 0.04 0.6160 ± 0.05 0.1000 ± 0.02
AVP  12.44 ± 0.83 12.74 ± 0.81 4.956 ± 0.71 5.016 ± 0.39 1.262 ± 0.07 1.386 ± 0. 10 0.6340 ± 0.03 0.6840 ± 0.04 0.5400 ± 0.05 0.5160 ± 0.05 0.5260 ± 0.06 0.1240 ± 0.02
Group symbols: C = control; D = dams; P = pups (M: male and F: female); A = atrazine; V = vitamin E; AV = atrazine + vitamin E.
Statistical  analysis:
Body  wt.  CP (M)  versus AP (M): *signiﬁcant difference at <0.05; CP (F) versus VP (F): *signiﬁcant difference at <0.05.
Relative wt.  of liver: CD versus AD: *signiﬁcant difference at <0.05.
Relative wt.  of kidneys: CP (F) versus AP (F): *signiﬁcant difference at <0.05.
Relative wt.  of heart: CD versus AD: *signiﬁcant difference at <0.05.
Table 2
Body  and relative organs weights of mouse dams and their pups exposed to atrazine, with and without vitamin E, during lactation.
Treatment groups B. wt.  (g) Relative organs weights (%)
Liver Kidneys Heart Spleen Ovary/testes
CD 27.63 ± 1.13 8.303 ± 0.84 1.470 ± 0.05 0.8067 ± 0.09 0.3633 ± 0.04 0.0800 ± 0.03
AD  29.43 ± 0.54 9.127 ± 0.22 1.560 ± 0.006 0.8000 ± 0.15 0.2767 ± 0.01 0.1067 ± 0.06
VD  27.20 ± 1.51 7.440 ± 0.90 1.377 ± 0.06 0.7200 ± 0.03 0.3833 ± 0.03 0.05333 ± 0.02
AVD  28.03 ± 0.18 9.653 ± 0.12 1.473 ± 0.024 0.8233 ± 0.14 0.2667 ± 0.05 0.08333 ± 0.05
Pups  M F M F M F M F M F M F
CP 7.00 ± 0.58 7.88 ± 0.68 5.542 ± 0.36 5.256 ± 0.40 1.436 ± 0.17 1.486 ± 0.13 0.8360 ± 0.11 0.8740 ± 0.10 0.5700 ± 0.07 0.5840 ± 0.05 0.5760 ± 0.08 0.0800 ± 0.03
AP  8.16 ± 0.89 6.78 ± 0.28 6.180 ± 0.94 6.342 ± 0.19* 1.422 ± 0.15 1.450 ± 0.06 0.6840 ± 0.05 0.7200 ± 0.03 0.5300 ± 0.07 0.6060 ± 0.12 0.4780 ± 0.07 0.7480 ± 0.05***
VP  8.30 ± 0.41 8.16 ± 0.25 6.352 ± 0.34 6.198 ± 0.14 1.498 ± 0.08 1.524 ± 0.02 0.7740 ± 0.02 0.7700 ± 0.02 0.5960 ± 0.8 0.5420 ± 0.06 0.4680 ± 0.08 0.0980 ± 0.01
AVP  6.48 ± 0.58 6.76 ± 0.38 5.834 ± 1.02 6.982 ± 0.31** 1.462 ± 0.13 1.524 ± 0.08 0.6200 ± 0.05* 0.6660 ± 0.05* 0.3040 ± 0.04 0.3900 ± 0.05 0.4820 ± 0.08 0.1040 ± 0.01
Group symbols: C = control; D = dams; P = pups (M:  male and F: female); A = atrazine; V = vitamin E; AV = atrazine + vitamin E.
Statistical  analysis:
–  No signiﬁcant differences in body weights.
– Liver: high signiﬁcant difference (<0.001): CP (F) versus AVP (F).
– Heart: signiﬁcant difference (<0.05): CP (M)  versus AVP (M)  and CP (F) versus AVP (F).
–  Ovary: high signiﬁcant difference (<0.001): CP (F) versus AP (F).
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Fig. 1. ALP activity in plasma of mouse dams and their pups exposed to
atrazine, with and without vitamin E, during gestation (a) and lactation (b)
periods. Statistical analysis: No signiﬁcant difference; *signiﬁcant differ-
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Fig. 2. Urea concentration in plasma of mouse dams and their pups
exposed to atrazine, with and without vitamin E, during gestation (a) and
lactation (b) periods. Statistical analysis: No signiﬁcant difference; *sig-ence at P < 0.05; **highly signiﬁcant difference at P < 0.01. Group symbols:
C = control; D = dams; P = pups (M:  male and F: female); A = atrazine;
V = vitamin E; AV = atrazine + vitamin E.
corresponding control values. The differences were statisti-
cally  signiﬁcant at P < 0.05 in case of dams, and were highly
signiﬁcant at P < 0.01 in case of pups. Similar pattern of ALP
elevation  was observed on mice of ATZ + vitamin E groups.
In  lactational exposure experiment, control values of
ALP  recorded 73.3, 54.7 and 54.3 IU/l for the mouse dams
(CD),  male pups CP (M)  and female pups CP (F), respec-
tively (Fig. 1b). The values recorded for ATZ-treated dams
and  their pups were highly signiﬁcant than the correspond-
ing  control values. Similar pattern of ALP elevation was
observed on mice of ATZ + vitamin E groups.
It  seemed that the elevation of ALP activity in ATZ-
treated group was higher in lactational than in gestational
exposure route, and the mouse pups were much vulner-
able  to alteration in ALP activity than their mothers in
both  cases compared. On the other hand, the vitamin treat-
ment  did not cause detectable alteration in ALP activity,
either in mouse dams or their offspring, while treatment
of ATZ + vitamin E induced high elevation of ALP activity in
the  dams and their pups (Fig. 1).In gestational exposure experiment (Fig. 2a), control
values of urea recorded 43.0, 34.3 and 34.7 mg/dl for
the  mouse dams (CD), male pups CP (M)  and female
pups CP (F), respectively. ATZ treatment induced highniﬁcant difference at P < 0.05; **highly signiﬁcant difference at P < 0.01.
Group symbols: C = control; D = dams; P = pups (M: male and F: female);
A = atrazine; V = vitamin E; AV = atrazine + vitamin E.
signiﬁcant increase (P < 0.01) accounting to 64.0, 57.3 and
58.7  mg/dl, respectively. Similar pattern of urea elevation
was  observed on mice of ATZ + vitamin E groups.
In lactational exposure experiment, control values of
urea  recorded 42.0, 34.7 and 35.0 mg/dl for the mouse dams
(CD),  male pups CP (M)  and female pups CP (F), respectively
(Fig. 2b). ATZ treatment induced high signiﬁcant increase
accounted to 62.7, 57.7 and 57.7 mg/dl, respectively.
The  results obtained indicate that urea elevation after
ATZ  treatment of mouse dams was somewhat higher
after gestational exposure than after lactational expo-
sure.  Mouse pups exhibited a similar pattern of urea
alterations as their mothers, both after gestational and lac-
tational  exposure. While vitamin E treatment did not cause
detectable alteration in urea concentration, either in mouse
dams  or their offspring, the treatment of ATZ + vitamin E
induced  high elevation of urea in the dams and their pups
(Fig.  2).
In  gestational exposure experiment, the butyryl
cholinesterase (BuChE) recorded 3419, 1503 and 1548 U/l,
respectively for control mouse dams, male offspring
and female offspring. In ATZ-treated groups, the above
mentioned values were generally declined and recorded
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Fig. 4. Concentration of MDA  in liver tissue of mouse dams and their pups
exposed to atrazine, with and without vitamin E, during gestation (a) and
lactation (b) periods. Statistical analysis: No signiﬁcant difference; *sig-iﬁcant difference at P < 0.05; **highly signiﬁcant difference at P < 0.01.
roup symbols: C = control; D = dams; P = pups (M:  male and F: female);
 = atrazine; V = vitamin E; AV = atrazine + vitamin E.
305 U/l in dams with high signiﬁcant difference at P < 0.01
Fig.  3a).
In  lactational exposure experiment, the butyryl
holinesterase (BuChE) recorded 3378, 1487 and 1544 U/l,
espectively for control mouse dams, male offspring
nd female offspring. In ATZ-treated groups, the above
entioned values were generally declined and recorded
298 U/l in dams, a value which was signiﬁcantly lower
P  < 0.05) than the corresponding control value (Fig. 3b).
The offspring (male and female) either in gestational or
actational exposures, in comparison with the correspond-
ng  control values, did not show signiﬁcant alteration in
uChE  activity (Fig. 3).
Control  values of malondialdehyde (MDA) concen-
ration in the gestational exposure experiment were
ccounted to 82.0, 52.3 and 51.3 nmol/g tissue for mouse
ams, male pups and female pups, respectively. In com-
arison, ATZ-treated groups recorded 93.3, 58.0 and
7.7  nmol/g tissue, respectively. Only, the value recorded
or  mouse dams was signiﬁcantly (P < 0.05) higher than that
ecorded  for control (Fig. 4a).
Concentration of MDA  for control animals in the lac-
ational exposure experiment equaled to 81.3, 53.0 and
1.0  nmol/g tissue for mouse dams, male pups and female
ups,  respectively. In comparison, ATZ-treated groups
ecorded 94.7, 58.3 and 59.0 nmol/g tissue, respectively.niﬁcant difference at P < 0.05; **highly signiﬁcant difference at P < 0.01.
Group symbols: C = control; D = dams; P = pups (M:  male and F: female);
A = atrazine; V = vitamin E; AV = atrazine + vitamin E.
Only the values recorded for mouse dams and female pups
were  signiﬁcantly (P < 0.05) higher than those recorded for
control  values (Fig. 4b).
Alterations  of superoxide dismutase (SOD) activity in
mouse  dams and their offspring following administration
of atrazine, with and without vitamin E, to the mothers
during gestational and lactational periods separately are
presented in Fig. 5. The general pattern of alteration was
a  decline of activity due to administration of ATZ. In ges-
tational exposure, SOD activity in mouse dams recorded
174.7 U/g tissue compared to control value of 210.0 U/g tis-
sue,  achieving high signiﬁcant difference at P < 0.01. The
pups,  either males or females, behaved similarly with
respect to high signiﬁcant decline of SOD activity. Also,
female and male pups from mother groups treated with
ATZ  + vitamin E showed lower enzyme activity compared
to  control (Fig. 5a).
In  lactational exposure experiment, control SOD activ-
ity  recorded 210.7, 190.7 and 190.3 U/g tissue for mouse
dams, male offspring and female offspring, respectively.
In ATZ-treated groups, these values were 180.7, 167.0
and  163.3 U/g tissue, achieving high signiﬁcant decline
(P  < 0.01) for mouse dams, signiﬁcant decline (P < 0.05) for
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Fig. 5. Activity of SOD in liver tissue of mouse dams and their pups
exposed to atrazine, with and without vitamin E, during gestation (a) and
lactation (b) periods. Statistical analysis: No signiﬁcant difference; *sig-
niﬁcant difference at P < 0.05; **highly signiﬁcant difference at P < 0.01.
Group symbols: C = control; D = dams; P = pups (M:  male and F: female);
A = atrazine; V = vitamin E; AV = atrazine + vitamin E.
male pups, and high signiﬁcant decline (P < 0.01) for female
pups  (Fig. 5b).
3.4.  Histopathology examination
Microscopic  examination of sections from liver, kidneys,
ovaries and testes prepared from the animals subjected
to different treatments in the present study was per-
formed. Fig. 6 illustrates the histopathologic structure of
the  studied organs prepared from the normal (control)
groups. The latter was considered as a base for comparing
the histopathologic alterations in ATZ and ATZ + vitamin E
groups.  Such alterations were scored in terms of degree
of  change in cells showing damage or alterations, as fol-
lows:  (0) = no change; (1) = mild change (e.g., <25% of cells
showing damage); (2) = moderate change (e.g., 25–50% cell
damage);  and (3) = severe change (e.g., >50% cell damage).
The  results are presented in Tables 4 and 5.
Sections of control organs (Fig. 6) were characterized
by normal histopathologic structure, observed on hepatic
lobules, central veins and appearance of hepatocytes. Renal
paranchyma and tubules showed normal histopathological
structure of kidneys. Grafﬁan follicle and corpus luteumeports 1 (2014) 53–68
were  characterized in normal ovary. Sections of testes were
characterized by normal seminiferous tubules, and ovaries
showed  normal corpus luteum (Fig. 6a–i).
In ATZ-treated groups during gestation (Table 4), the
following histopathologic effects were observed:
- Liver: mild hepatic and moderate vacuolar degeneration
of hepatocytes (dams, male and female pups); moderate
perivascular mononuclear cells inﬁltration accompanied
with mild Kupffer cells activation (dams) and moderate
ﬁbroblast proliferation around bile duct (female pups).
- Kidneys: moderate vacuolation of epithelial lining renal
tubules and glomerular tuft (dams, male and female
pups); moderate focal renal hemorrhage (dams); mod-
erate thickening of parietal layer of Bowman’s capsule
(dams) and mild congestion of intertubular blood vessels
(female pups).
- Ovary: moderate degeneration of corpus luteum and
moderate congestion of blood vessels (dams).
-  Testis: moderate degeneration of spermatogoneal cells;
moderate thickening of basement membrane of sem-
iniferous tubules, as well as mild small diameter
seminiferous  tubules.
In ATZ + vitamin E-treated groups during gestation
(Table 4), most (if not all) of the above histopathologic
changes disappeared, except for some mild changes rep-
resented by hepatic degeneration of hepatocytes (male
pups); mild vacuolar degeneration of hepatocytes, as well
as  kupffer cells activation (dams).
In ATZ-treated groups during lactation (Table 5), the
following histopathologic effects were observed:
- Liver: mild hepatic degeneration of hepatocytes (female
pups); severe (dams) to moderate (pups) vacuolar degen-
eration of hepatocytes; mild perivascular mononuclear
cells inﬁltration (male pups); mild ﬁbroblast prolifera-
tion around bile duct (male pups) and severe focal hepatic
hemorrhage (dams and male pups).
-  Kidneys: severe vacuolation of epithelial lining renal
tubules (dams and offspring); moderate vacuolation of
epithelial lining glomerular tuft (dams and male pups),
but mild for female pups; severe focal renal hemorrhage
(dams)  and moderate congestion of intertubular blood
vessels (dams).
- Ovary: moderate (dams) and mild (female pups) degen-
eration of corpus luteum and severe congestion of blood
vessels (dams).
- Testis: moderate degeneration of spermatogoneal cells,
mild thickening of basement membrane of seminiferous
tubules, moderate small diameter seminiferous tubules
and severe intratubular odema.
In  ATZ + vitamin E-treated groups during lactation
(Table 5), most (if not all) of the above histopathologic
changes disappeared or declined, except for some effects
represented by mild kupffer cells activation (male pups);
mild  vacuolation of epithelial and endothelial lining renal
tubules  (dams) and mild degeneration of spermatogoneal
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Fig. 6. Histopathological sections for organs (liver, kidney, ovary and testis) prepared from normal mice for comparison with atrazine-treated mice, with
and  without vitamin E, during gestation and lactation periods (H&E stain 400×). (a) Liver of control mouse dam showing the normal histological structure
of  hepatic lobule from central vein (CV) and normal hepatocytes (H) (H&E stain 400×). (b) Liver of control male offspring showing the normal histological
structure  of hepatic lobule from central vein (CV) and normal hepatocytes (H) (H&E stain 400×). (c) Liver of control female offspring showing the normal
histological  structure of hepatic lobule from central vein (CV) and normal hepatocytes (H) (H&E stain 400×). (d) Kidney of control mouse dam showing
the  normal histological structure of renal parenchyma. Note normal glomerulus (G) and normal renal tubules (T) (H&E 400×). (e) Kidney of control male
offspring  showing the normal histological structure of renal parenchyma. Note normal glomerulus (G) and normal renal tubules (T) (H&E 400×). (f) Kidney
of  control female offspring showing the normal histological structure of renal parenchyma. Note normal glomerulus (G) and normal renal tubules (T) (H&E
400×).  (g) Ovary of control mouse dam showing normal grafﬁan follicle (GF) and normal corpus luteum (CL). (H&E stain 400×). (h) Ovary of female offspring
showing  normal grafﬁan follicle (GF) (H&E stain 400×). (i) Testis of control male offspring showing normal seminiferous tubules (ST) (H&E stain 400×).
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cells (male pups). Numerous follicles were seen in a section
of  ovary from the pups.
4.  Discussion
In toxicological studies, organ and relative organs
weights are important criteria for evaluation of organ tox-
icity  [47], and increase or decrease of organs weights than
normal  may  be considered as a sign of toxicity [48]. Several
investigators (e.g., [36,37,49,50]) have reported the effect
of  ATZ on body and internal organs weights, as well as
on  the function of liver and kidney. Therefore, our ﬁnd-
ings  may  add further awareness to possible effects of the
tested  dose in the present study which was extremely
lower than the doses used by the previous investigators.
In lactational exposure experiment, the relative weights of
liver  and heart from the ATZ + vitamin E group of pups (AVP;
Table  2) have exercised signiﬁcant differences compared
to  the corresponding control values. Such result may  refer
to  interaction between the pesticide and vitamin E which
appeared as “potentiating effect” for liver and “antagonistic
effect” for heart, a result which may  need further investi-
gation in future studies.
Hepatic  effects of ATZ in terms of enzymatic alteration
had been studied in different animal species. In the present
study,  elevation (P < 0.05) of ALP activity was observed in
ATZ-treated dams during gestation (group AD; Fig. 1a), and
high  elevation (P < 0.01) for those treated during lactation
(group AD; Fig. 1b), results which coincide with that of
Santa  Maria et al. [49] on Wister rats treated with ATZ at
100  mg  kg−1/day for 14 days. Either in gestational or lacta-
tional  exposure, the mouse pups showed elevation of ALP
activity  very higher than that in the dams, a result reﬂecting
high  vulnerability of the young mice to indirect exposure
to  ATZ via their mothers.
Alkaline  phosphatases are a group of enzymes found
primarily in the liver (isoenzyme ALP-1) and bone (isoen-
zyme  ALP-2). There are also small amounts produced by
cells  lining the intestines (isoenzyme ALP-3), the placenta,
and  the kidney (in the proximal convoluted tubules). What
is  measured in the blood is the total amount of ALP released
from  these tissues into the blood. The primary importance
of  measuring ALP is to check the possibility of bone disease
or  liver disease. When the liver, bile ducts or gallblad-
der system are not functioning properly or are blocked,
this enzyme is not excreted through the bile and ALP is
released  into the blood stream [51]. On the other side, the
observed  high elevation (P < 0.01) of urea concentration
may  be considered as an indication of kidney dysfunc-
tion due to exposure to ATZ at such very low dose used
in  the present study. Our results coincide with those previ-
ously  reported regarding the profound effect of ATZ on liver
and  kidney functions in a variety of experimental animals
[36,37,49,50].
Cholinesterase (ChE, 3.1.1.8), also known as pseudo-
cholinesterase, has been recognized as an enzyme that
hydrolyzes choline esters. It is synthesized mainly in hep-
atocytes  and secreted into the blood stream [52]. ChE
activity is reduced in liver dysfunction due to reduced
synthesis, in contrast to other serum enzymes associ-
ated with the clinical assessment of liver function whoseeports 1 (2014) 53–68
activities increase as a result of increased release from
their cellular sources following cell membrane damage
[53]. Cholinesterases had been long recognized as biomark-
ers  of effect induced mainly by organophosphorus and
carbamate pesticides [54]; so, investigations on other anti-
cholinesterases were being limited. To the best of our
knowledge, the literature offers very little information
about the effect of atrazine on mammals ChEes activity,
while much studies on aquatic vertebrate organisms are
available  in the literature with special concern to joint
action of ATZ and other pesticides [55–58]. This led Boon-
thai  et al. [55] to suggest that AChE as a biomarker for
organophosphorus and carbamate pesticides may  be valid
to  use for other chemical groups.
In a single paper, it was  reported that administration
of ATZ to rats at 300 mg  kg−1 affected erythrocyte mem-
branes causing signiﬁcant inhibition of AChE activity and
induction of oxidative stress in terms of increased mal-
ondialdehyde (MDA) levels. However, administration of
vitamin  E (100 mg  kg−1 bw daily) ameliorated the oxidative
stress and changes in the erythrocyte membranes induced
by  ATZ [59]. Such results corroborated our ﬁndings regard-
ing  high signiﬁcant (P < 0.01) decline of BuChE activity in
ATZ-treated mouse dams during gestation (Fig. 3a), and
signiﬁcant (P < 0.05) decline in ATZ-treated mouse dams
during  lactation (Fig. 3b). In both cases of exposure to ATZ,
co-administration of vitamin E normalized the enzyme
activity to that of the control values. It seemed that there
were  no signiﬁcant alteration in BuChE activities in the
pups  whose mothers were treated with ATZ either during
gestation or lactation stages (Fig. 3). This may  be referred
to  the administered low dose of ATZ which is not strong
inhibitor to cholinesterase enzymes [58].
In fact, the toxicity of many xenobiotics is associated
with the production of oxygen-free radicals, more gener-
ally  known as “reactive oxygen species” (ROS), which are
not  only toxic themselves but are also implicated in the
pathophysiology of many diseases [60]. The harmful effects
of  ROS are balanced by the antioxidant action of nonenzy-
matic antioxidants in addition to antioxidant enzymes [61].
Antioxidants protect cells from the damaging effects of free
radicals,  which are molecules that contain an unshared
electron [62]. It has been reported that many pesticides
may  induce oxidative stress following acute exposure in
humans  [63] and animals [64–67]. Increased lipid peroxi-
dation (LPO) in various tissues may  be one of the molecular
mechanisms involved in the ATZ-induced toxicity. SOD
provides the ﬁrst line of defense against oxygen derived
free  radicals and decreases oxidative stress by dismutation
of  O2− [68]. Previous studies in our laboratory on rat (Rattus
norvegicus), using different insecticides, revealed increase
of  LPO and decrease of SOD levels following the insecticidal
treatments [64–67,69–71], and corroborate our ﬁndings on
ATZ  herbicide. Also, oral administration of ATZ to rats at
120  mg  kg−1 was found to impair the antioxidant defense
and increased LPO (in terms of MDA  concentration) in the
liver  and signiﬁcantly decreased SOD activity [72].Vitamin E is an important biological free radical
scavenger in the cell membranes [33]. In the present
investigation we studied whether vitamin E has the poten-
tial  to attenuate ATZ-induced oxidative stress, either in
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ouse dams exposed during gestation or during lactation
s  well as on their offspring. In mouse dams, the signiﬁ-
ant  (P < 0.05) elevation of MDA  induced by ATZ and the
igh  signiﬁcant decline (P < 0.01) of SOD were normalized
ith co-administration of vitamin E (Figs. 4 and 5). More-
ver,  the female pups from lactation experiment (Fig. 4b)
howed  signiﬁcant elevation of MDA  activity which was
eturned to its normal value by co-administration of vita-
in  E. Such results coincide with Singh et al. [6] who
ound a signiﬁcant increase in hepatic LPO following ATZ
dministration to male Wistar rats at 300 mg  kg−1 bw,  but
dministration of vitamin E (100 mg  kg−1 bw)  attenuated
TZ-induced LPO in liver. According to Pascoe et al. [73],
itamin E allows free radicals to abstract a hydrogen atom
rom  the antioxidant molecule rather than from polyun-
aturated fatty acids (PUFA), thus breaking the chain of
ree  radical reactions. The resulting antioxidant radical is
elatively  a non- reactive species.
To assess the effect of ATZ on antioxidative stress
nzymes (e.g., MDA  and SOD) in a “quantitative manner”,
e  calculated the percentage of change in ATZ-treated
roups relative to control untreated groups, either for the
ams  or their offspring, both in cases of gestational and
actational exposures. According to the data presented in
able  3, the average of change in MDA  and SOD in the pups
f  gestational exposure was accounted to 11.6% and 15.1%,
espectively, compared to 12.8% and 13.3%, respectively for
he  pups of lactational exposure (based on calculating the
verage  of the values of male and female pups given in
he  table). For the dams, the change accounted to 13.8%
nd  16.8% in gestation and 16.4% and 14.3% in lactation.
his means that the effect on MDA  was more pronounced
n ATZ exposure during lactation, while the opposite for
OD  which was more pronounced in ATZ exposure dur-
ng  gestation. Interestingly, such trend was obtained either
or  the dams or their offspring (Table 3). Such ﬁndings
learly demonstrate that pups have exercised degree of
ffects  nearly equaled to that their mothers were affected.
ndeed, the differences between the two cases compared
ere small, may  be due to the low dose of ATZ used in the
resent  study (31.0 g kg−1). On the other hand, we com-
ared the results of MDA  and SOD in ATZ/vit. E groups with
he  results of control groups, to assess the ameliorative
ffect of vitamin E, based on calculating the “Ameliora-
ive Index; AI”. As AI approaching “1”, as the amelioration
eaching high degree of normalization to the control value.
he  obtained results revealed that the AI of MDA  and SOD
anged  between 0.95 and 1.06 (≈1.0) for the dams and
ups  either in gestational or lactational exposure routes.
imilar assessment could be carried out on BuChE changes
ue  to exposure to ATZ, and the ameliorative efﬁciency
f  co-administration of vitamin E. Generally, changes due
o  ATZ were little and accounted to 1.5–3.4% in gestation
nd 1.9–4.0% in lactation. The AI was accounted to approx-
mately 1.0 for the two studied cases (Table 3).
Pregnant women are a special risk group, given the ﬁnd-
ngs  showing increased risk of childhood acute lymphocytic
eukemia when women use pesticides in the home and
arden  during pregnancy [74]. On the other hand, lacta-
ion  may  pose stress to the mothers and such mothers will
e  more vulnerable, than non-lactating mothers, to othereports 1 (2014) 53–68 63
chemical  stressors [75]. It is documented that the fetus is
more  vulnerable to the toxic effects of a number of environ-
mental exposures than are children or adults [76]. Highly
lipophilic compounds are expected to cross the placenta
and reach the fetus during pregnancy [77,78]. Also, there
are  many factors involved in the transfer of chemicals into
the  milk and subsequently to the suckling neonate, includ-
ing  lipophilicity, ionization and maternal plasma protein
binding, which can all inﬂuence transport of the compound
during lactation [79]. ATZ is a lipophilic compound and has
a  low molecular weight compatible with passive diffusion
and  transfer from the dam to the pup [80,81]. In their stud-
ies  on gestational and/or lactational exposure of Sprague
Dawley dams to ATZ (0, 1, 5, 20, or 100 mg  kg−1/day), Fraites
et  al. [21] concluded that placenta does not appear to limit
the  transfer of ATZ and its metabolites from the maternal
circulation to the developing fetus. Also, levels of ATZ and
the  metabolites were found in neonatal milk, plasma and
tissues.  It worthy to mention that chlorinated metabolites
of ATZ [e.g., diethylatrazine (DEA), di-isopropyl-atrazine
(DIA), and diaminochlorotriazine (DACT)] are considered
equivalent in toxicity to ATZ, and exposure to metabolites
are also of concern [19,82]. Atrazine and its metabolites
were found to contaminate human blood in Japan [83],
women mammary fat tissue in Argentina [84] and milk in
British  mothers (around 0.5.2.3 g/g) [85].
In  the present study, the pups were exposed to ATZ
intoxication via placenta and breast milk in the experiment
of  gestational exposure, and via breast milk only in the sec-
ond  experiment (lactational exposure). In an attempt to
elucidate  which stage of exposure (gestation or lactation)
to  ATZ was  more affected, we  estimated alteration of MDA
and  SOD (as examples) following ATZ treatments, based
on  the data presented in Table 3. The average of change
in  MDA  and SOD in the pups of gestational exposure was
accounted to 11.6% and 15.1%, respectively, compared to
12.8%  and 13.3%, respectively for the pups of lactational
exposure (based on calculating average of the values of
male  and female pups given in the table). For the dams,
the  change accounted to 13.8% and 16.8% in gestation and
16.4%  and 14.3% in lactation. This means that the effect
of  ATZ on MDA  was  more pronounced during lactation,
while the opposite for SOD which was  more pronounced
during gestation. Interestingly, such trend was obtained
either for the dams or their offspring (Table 3). Performing
similar calculations with ALP may  give additional picture.
In  gestational exposure experiment, ALP activity equaled
75.3  and 56.1 IU/l for control dams and their pups (with-
out  sex differentiation), respectively. ATZ-treated groups
showed 101.7 and 125.3 IU/l, respectively (Fig. 1a). In lac-
tational  exposure experiment, these values equaled 73.3
and  54.5 IU/l, respectively for control animals, and 95 and
122.3  IU/l for ATZ-treated groups (Fig. 1b). This means
that, in gestation experiment, the change in ALP activity
was accounted to 35.1% and 123.4% for dams and their
pups,  respectively, while changes in ALP activity in lacta-
tion  experiment reached 29.6% and 124.4%, respectively for
dams  and their pups. This means that the effect of ATZ on
ALP  in mouse dams was  higher during gestation than dur-
ing  lactation. The effect on pups-ALP was  nearly equal in
both  gestational and lactational exposure.
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Table  3
Assessment of oxidative stress of atrazine and the ameliorative effect of vitamin E, based on measured biochemical parameters from gestation and lactation
experimental  results.
Mice/parameter Control (a) ATZ (b) ATZ + E (c) % of changea Ameliorative Index (AI)b
Gestationc
MDA (nmol/g tissue)
Dams  82.00 93.33 87.33 13.8 1.06
Pups  (M) 52.33 58.00 55.33  10.8 0.95
Pups  (F) 51.33 57.70 54.70 12.4 0.95
SOD  (U/g tissue)
Dams  210.00 174.60 183.33 −16.8 1.05
Pups  (M)  190.00 162.70 171.00 −14.4 1.05
Pups  (F) 190.70 160.60 168.60 −15.8 1.05
BuChE  (U/l)
Dams  3419.0 3305 3358 −3.3 1.02
Pups  (M)  1503.3 1452 1477 −3.4 1.02
Pups  (F) 1548.0 1525 1540 −1.5 1.00
Lactationc
MDA (nmol/g tissue)
Dams  81.33 94.7 86.0 16.4 0.91
Pups  (M)  53.00 58.3 54.7 10.0 0.94
Pups  (F) 51.00 59.0 55.0 15.7 0.93
SOD  (U/g tissue)
Dams  210.7 180.6 187.0 −14.3 1.03
Pups  (M)  190.6 167.0 177.6 −12.4 1.06
Pups  (F) 190.3 163.3 173.3 −14.2 1.06
BuChE  (U/l)
Dams  3379 3298 3341 −2.4 1.01
Pups  (M) 1487 1427 1448 −4.0 1.01
Pups  (F) 1544 1514 1527 −1.9 1.00
a Percent of change = (b − a)/a × 100.
b Ameliorative Index (AI) = c/a.
c Data under gestation and lactation are mean values for the respective biochemical parameters.
Table 4
Histopathologic changes based on scoring severity of injury in different organs from mouse dams and their pups following exposure to atrazine with and
without  vitamin E during gestation.
Histopathological changes Treatments
ATZ ATZ + vit. E
Dams Pups (M)  Pups (F) Dams Pups (M)  Pups (F)
Liver
Hepatic degeneration of hepatocytes 1 1 1 0 1 0
Vacuolar degeneration of hepatocytes 2 2 2 1 0 0
Perivascular mononuclear cells inﬁltration 2 0 0 0 0 0
Fibroblast proliferation around bile duct 0 0 2 0 0 0
Focal hepatic haemorrhage 0 0 0 0 0 0
Kupffer cells activation 1 0 0 1 0 0
Kidneys
Vacuolation of epithelial lining renal tubules 2 3 3 0 0 0
Vacuolation of endothelial lining glomerular tuft 2 2 2 0 0 0
Focal renal haemorrhage 2 0 0 0 0 0
Thickening of parietal layer of Bowman’s capsule 2 0 0 0 0 0
Congestion of intertubular blood vessels 0 0 1 0 0 0
Ovary
Degeneration of corpus luteum 2 0 0 0
Congestion of blood vessels 2 0 0 0
Numerous follicles 0 0 0 2
Testis
Degeneration of spermatogoneal cells 2 0
Thickening of basement membrane of seminiferous tubules 2 0
Small diameter seminiferous tubules 1 0
Intratubular odema 0 0
Degree of changes: (0) = no change; (1) = mild change (e.g., <25% of cells showing damage); (2) = moderate change (e.g., 25–50% cell damage); and (3) = severe
change  (e.g., >50% cell damage).
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Table 5
Histopathologic changes based on scoring severity of injury in different organs from mouse dams and their pups following exposure to atrazine with and
without  vitamin E during lactation.
Histopathological changes Treatments
ATZ ATZ + vit. E
Dams Pups (M) Pups (F) Dams Pups (M)  Pups (F)
Liver
Hepatic degeneration of hepatocytes 0 0 1 0 0 0
Vacuolar degeneration of hepatocytes 3 2 2 0 0 0
Perivascular mononuclear cells inﬁltration 0 1 0 0 0 0
Fibroblast proliferation around bile duct 0 1 0 0 0 0
Focal hepatic haemorrhage 3 3 0 0 0 0
Kupffer cells activation 0 0 0 0 1 0
Kidneys
Vacuolation of epithelial lining renal tubules 3 3 3 1 0 0
Vacuolation of endothelial lining glomerular tuft 2 2 1 1 0 0
Focal renal haemorrhage 3 0 0 0 0 0
Thickening of parietal layer of Bowman’s capsule 0 0 0 0 0 0
Congestion of intertubular blood vessels 2 0 0 0 0 0
Ovary
Degeneration of corpus luteum 2 1 0 0
Congestion of blood vessels 3 0 0 0
Numerous follicles 0 0 0 3
Testis
Degeneration of spermatogoneal cells 2 1
Thickening of basement membrane of seminiferous tubules 1  0
Small diameter seminiferous tubules 2 0
D wing da
c
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egree of changes: (0) = no change; (1) = mild change (e.g., <25% of cells sho
hange  (e.g., >50% cell damage).
Indeed, the response of the antioxidant enzymes (e.g.,
DA  and SOD) to ATZ was lower than the response of ALP,
nd  that may  refer to the low dose of ATZ used in the
resent study (31.0 g kg−1), and the different response of
uch  biomarkers to a toxicant such as ATZ.
Exposure of mice dams to ATZ at the equivalent dose
o  its ADI (ca. 0.005 mg  kg−1 bw/d) has resulted in notice-
ble histopathological effects on liver, kidney, ovary and
estis  as illustrated in Fig. 6 and Tables 4 and 5. The off-
pring from the treated dams generally exercised nearly
imilar effects. Histologically, it has been reported that
TZ  caused liver degeneration represented by chronic
nterstitial inﬂammation, lymphocyte and eosinophil inﬁl-
ration,  and narrowing and irregular forms of bile canaliculi
49,86]. Also, it induced multiple ovarian follicular cysts
nd  persistence of corpus luteum [87], as well as kid-
ey  dysfunction represented by an increase in the protein
ontent of the urine in rats treated for 14 days with
0 mg  kg−1 of ATZ per day [88]. In the present study, bio-
hemical alterations observed in ATZ-treated mice and
ormalization levels of these biochemical parameters after
dministration of vitamin E corroborated the results of
istopathological ﬁndings, where vitamin E supplemen-
ation repaired the impairment of ATZ to the studied
rgans.
. ConclusionIn  light of the results of the present study, it can be con-
luded that exposure of adult female mice to contaminated
ood with ATZ at its acceptable daily intake (ADI) level can0
mage); (2) = moderate change (e.g., 25–50% cell damage); and (3) = severe
induce  hepatic and renal oxidative stress and histopatho-
logical effects. Since mouse pups from dams exposed to
ATZ  during lactation were dependent only on breast feed-
ing,  the ﬁndings of the present investigation reveal that
toxic  effects of ATZ, as well as ameliorative effect of vita-
min  E, occurred via lactation process. In pups from dams
exposed to ATZ during gestation, the toxic effects of ATZ,
as  well as ameliorative effect of vitamin E, occurred mainly
via  gestation and probably through the mother’s milk also.
In  light of the results of the present study, it may  be dif-
ﬁcult  to conclude, in a general statement, which exposure
stage was much affected following exposure to ATZ. But
we  can suggest which stage was  more vulnerable to alter-
ation  of a speciﬁc parameter (e.g., MDA, SOD, ALP, etc.).
For  instance, the effect of ATZ on ALP in mouse dams was
higher  during gestation than during lactation. The effect
on  MDA  was  more pronounced in ATZ exposure during
lactation, while the opposite for SOD which was more pro-
nounced  in ATZ exposure during gestation. The response
of  MDA  and SOD was similar either for the dams or their
offspring. Histologically, ATZ induced impairment in tis-
sues  of the experimental dams and their offspring, both in
those  exposed during gestation and lactation. Taking into
consideration that exposure of dams to ATZ during gesta-
tion  was  followed with a withdrawal period (ca. 21 days),
this  may lead us to consider that gestation stage was more
affected  than lactation stage. The ﬁndings may  support the
need  to further investigating the adverse effects of expo-
sure  to low doses of commonly used pesticides, especially
during pregnancy and breast-feeding as well as effects on
newborn  child.
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